Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;18(6):4904-4912.
doi: 10.3892/etm.2019.8146. Epub 2019 Oct 30.

Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases

Affiliations

Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases

Katarzyna Jakubowska et al. Exp Ther Med. 2019 Dec.

Abstract

The presence of tumor cells in the large intestine stimulates hypoxia and local inflammatory mediators that activate numerous inflammatory cells, including a diverse lymphoid tumor cell population. The aim of the present study was to evaluate tumor-infiltrating lymphocytes (TILs) located in the invasive primary tumor, surrounding deposits of tumor cells and those present in distal metastatic cells in the liver of patients with colorectal cancer. Furthermore, the correlation of TILs with anatomical parameters was assessed. The study group included 123 patients with primary tumor colorectal cancer without distant metastasis, 25 cases with deposits of colorectal cancer cells and 15 cases of colorectal cancer liver metastasis. TILs were assessed in tissues stained with hematoxylin-eosin using light microscopy and evaluated by two independent pathologists blinded to the clinical information. Infiltration of TILs in the invasive front of primary tumor was stronger compared with those surrounding deposits of cancer cells and liver metastases (P<0.001). TILs in the invasive front of primary tumor masses were associated with various variables linked with tumor progression and inflammatory cell infiltrate. TILs distributed around the deposits of cancer cells were associated with postoperative treatment; however, those localized in the invasive front of liver metastases were correlated with preoperative therapy. In conclusion, TILs assessment in primary tumors of colorectal cancer, surrounding deposits of tumor cells and in the metastatic cells in the liver may be helpful in understanding the role of these cells in the organization of immune response.

Keywords: colorectal cancer liver metastasis; deposits; tumor-infiltrating lymphocytes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of TILs. TIL distribution was observed (A) in the invasive front of primary tumor (strong cell infiltrate), (B) those surrounding deposits of cancer cells (weak cell infiltrate) and (C) in the invasive front of distant metastatic cells in the liver (weak cell infiltrate). Evaluation of TILs was performed using hematoxylin and eosin-stained sections. Magnification, ×200 in (A and C) and ×200 in (B) TILs, tumor-infiltrating lymphocytes.
Figure 1.
Figure 1.
Distribution of TILs. TIL distribution was observed (A) in the invasive front of primary tumor (strong cell infiltrate), (B) those surrounding deposits of cancer cells (weak cell infiltrate) and (C) in the invasive front of distant metastatic cells in the liver (weak cell infiltrate). Evaluation of TILs was performed using hematoxylin and eosin-stained sections. Magnification, ×200 in (A and C) and ×200 in (B) TILs, tumor-infiltrating lymphocytes.
Figure 1.
Figure 1.
Distribution of TILs. TIL distribution was observed (A) in the invasive front of primary tumor (strong cell infiltrate), (B) those surrounding deposits of cancer cells (weak cell infiltrate) and (C) in the invasive front of distant metastatic cells in the liver (weak cell infiltrate). Evaluation of TILs was performed using hematoxylin and eosin-stained sections. Magnification, ×200 in (A and C) and ×200 in (B) TILs, tumor-infiltrating lymphocytes.

Similar articles

Cited by

References

    1. Jakóbisiak M, Lasek W. Immunologia nowotworów. In: Gołąb J, Jakóbisiak M, Lasek W, Stokłosa T, editors. Immunologia. 5th. Wydawnictwo Naukowe PWN; Warszawa: 2007. pp. 478–484.
    1. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10:3755–3762. doi: 10.1158/1078-0432.CCR-04-0054. - DOI - PubMed
    1. Edge SB, Byrd D, Compton CC, Fritz AG, Greene F, Trotti A. AJCC Cancer Staging Manual. 7th. Springer; New York, NY: 2010. American Joint Committee On Cancer.
    1. Kumar S, Skeen MJ, Adiri Y, Yoon H, Vezys VD, Lukacher AE, Evavold BD, Ziegler HK, Boss JM. A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets. Cell Immunol. 2005;237:131–140. doi: 10.1016/j.cellimm.2005.11.003. - DOI - PubMed
    1. Kwak Y, Koh J, Kim DW, Kang SB, Kim WH, Lee HS. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. Oncotarget. 2016;7:81778–81790. doi: 10.18632/oncotarget.13207. - DOI - PMC - PubMed